Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18690106 | SYSTEMS AND METHODS FOR EVALUATING RELIABILITY OF A PATIENT EARLY WARING SCORE | March 2024 | March 2026 | Abandon | 24 | 1 | 0 | No | No |
| 18594327 | METHOD AND SYSTEM FOR GENERATING PHYSICAL ACTIVITY RECOMMENDATIONS AND NON-TRANSITORY COMPUTER READABLE STORAGE MEDIUM | March 2024 | March 2026 | Allow | 24 | 1 | 0 | No | No |
| 18431060 | SYSTEM AND METHOD FOR DRUG SELECTION | February 2024 | February 2026 | Abandon | 25 | 1 | 0 | No | No |
| 18282795 | METHOD FOR PROVIDING VISUALIZED CLINICAL INFORMATION AND ELECTRONIC DEVICE | September 2023 | January 2026 | Abandon | 28 | 1 | 0 | No | No |
| 18223006 | MODERATED COMMUNICATION SYSTEM FOR INFERTILITY TREATMENT | July 2023 | January 2026 | Allow | 30 | 2 | 0 | No | No |
| 18316130 | HEALTH AND MEDICAL HISTORY VISUALIZATION AND PREDICTION USING MACHINE-LEARNING AND ARTIFICIAL INTELLIGENCE MODELS | May 2023 | October 2025 | Abandon | 29 | 1 | 0 | No | No |
| 18142884 | Method for Tracking and Managing Specimens Collected at Remote Collection Locations | May 2023 | March 2026 | Abandon | 34 | 1 | 0 | No | No |
| 18166039 | SYSTEM AND PROCESS FOR MONITORING A PATIENT | February 2023 | December 2025 | Abandon | 35 | 2 | 0 | No | No |
| 17935970 | SYSTEMS AND METHODS FOR VERIFYING PATIENT IMMUNITY | September 2022 | December 2025 | Abandon | 47 | 2 | 0 | No | No |
| 17877767 | COMPUTER ARCHITECTURE FOR IDENTIFYING LINES OF THERAPY | July 2022 | October 2025 | Allow | 39 | 3 | 0 | No | No |
| 17487663 | AUTOMATICALLY IDENTIFYING PRESSURE INJURIES | September 2021 | February 2026 | Allow | 53 | 4 | 0 | Yes | No |
No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.
Examiner ILAGAN, VINCENT CAESAR works in Art Unit 3686 and has examined 1 patent applications in our dataset. With an allowance rate of 100.0%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 53 months.
Examiner ILAGAN, VINCENT CAESAR's allowance rate of 100.0% places them in the 100% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.
On average, applications examined by ILAGAN, VINCENT CAESAR receive 4.00 office actions before reaching final disposition. This places the examiner in the 97% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by ILAGAN, VINCENT CAESAR is 53 months. This places the examiner in the 3% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
When applicants file an RCE with this examiner, 0.0% of applications are subsequently allowed. This success rate is in the 1% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 50.0% of cases where such amendments are filed. This entry rate is in the 76% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 40% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 43% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.